Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis [NA]
Clinical trial update reporting the completion of a study testing Uridine Triphosphate (UTP) delivered as an aerosol spray for cystic fibros…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis [NA]
A clinical trial evaluating tauroursodeoxycholic acid for hepatobiliary disease in cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis [NA]
This clinical trial update investigates the use of ibuprofen to preserve lung function in patients with cystic fibrosis and notes the study …
-
CLINICAL_TRIALS withdrawal · 2015-03-18Clinical Trial Update: Microbiota of the Respiratory Flora in Children With Cystic Fibrosis During the First Year of Life
The clinical trial evaluating the respiratory microbiota in infants with cystic fibrosis during the first year of life has been withdrawn.
-
FDA approval · 2015-03-17FDA Approved: KALYDECO — Original Application (Vertex Pharmaceuticals Incorporated)
The FDA granted original approval of KALYDECO (ivacaftor) from Vertex Pharmaceuticals under NDA 207925. It is approved for the treatment of …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Pilot Study of Behavioural Intervention for Nutrition in Cystic Fibrosis [NA]
A pilot trial evaluating a behavioural intervention to support nutrition in cystic fibrosis has completed.
-
FDA approval · 2015-03-09FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
The FDA approved a supplemental application for KALYDECO (ivacaftor) from Vertex Pharmaceuticals Incorporated, resulting in changes to the d…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients [Phase 1]
Phase 1 trial evaluating the safety and tolerability of CTX-4430 in cystic fibrosis patients has completed.
-
FDA approval · 2015-03-04FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
The FDA approved a supplemental application for KALYDECO (ivacaftor) submitted by Vertex Pharmaceuticals, resulting in updated labeling for …
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis
This clinical trial update indicates that the study investigating lubiprostone's effects on nutritional status and pulmonary function in adu…
-
FDA approval · 2015-03-03FDA Approved: PANCREAZE — Supplemental Application (VIVUS LLC)
The FDA approved a supplemental application for PANCREAZE (pancrelipase) from VIVUS LLC.
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: Interest of Gentamicin-induced Readthrough in Cystic Fibrosis Patients [Phase 2]
A Phase 2 trial evaluating gentamicin-induced readthrough in cystic fibrosis patients was terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF) [Phase 3]
Phase 3 trial evaluating Ultrase MT12 in young children with cystic fibrosis and pancreatic insufficiency has completed, and results have be…
-
FDA approval · 2015-02-16FDA Approved: TOBRAMYCIN INHALATION — Supplemental Application (Prasco, LLC)
The FDA approved a supplemental application for Tobramycin Inhalation submitted by Prasco, LLC, signaling regulatory clearance for this inha…
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: A Study in Adult and Pediatric Patients With Cystic Fibrosis [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating an experimental therapy for cystic fibrosis in adult and pediatric patients, sponsored by Me…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT) [Phase 3]
A Phase 3 trial of Ivacaftor in cystic fibrosis patients carrying the R117H CFTR mutation (KONDUCT) has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis [Phase 4]
This Phase 4 clinical trial update presents long-term safety data for tobramycin inhalation powder in people with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: A Study to Investigate Lung Deposition of Radiolabelled OligoG [Phase 2]
A Phase 2 study evaluating the lung deposition of radiolabelled OligoG in cystic fibrosis patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease [Phase 2]
A Phase 2 study evaluating INS37217 inhalation solution for mild to moderate cystic fibrosis lung disease has completed.
-
CLINICAL_TRIALS withdrawal · 2015-01-15Clinical Trial Update: Long Term Significance (Survival) of LCI in Patients With Cystic Fibrosis
This clinical trial update indicates a study evaluating the long-term significance of Lung Clearance Index (LCI) in cystic fibrosis patients…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment [Phase 2]
A Phase 2 trial evaluating KB001-A on time-to-need for antibiotic treatment in cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Glutamine Supplementation in Cystic Fibrosis [Phase 2]
Phase 2 clinical trial evaluating glutamine supplementation in cystic fibrosis has completed, with investigation of effects on immune functi…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis [Phase 1, Phase 2]
A cross-over study of OligoG in subjects with cystic fibrosis has completed Phase 1 and Phase 2 trials.
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: A Safety and Tolerability Study of Denufosol in 2-4 Year Olds [Phase 2]
A phase 2 safety and tolerability study of denufosol in 2- to 4-year-old children with cystic fibrosis has completed.
-
FDA approval · 2015-01-12FDA Approved: CAYSTON — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Cayston (aztreonam) by Gilead Sciences, Inc.